154 related articles for article (PubMed ID: 30385068)
21. Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments.
Vardi M; Kochavi T; Denekamp Y; Bitterman H
Isr Med Assoc J; 2012 Feb; 14(2):115-8. PubMed ID: 22693794
[TBL] [Abstract][Full Text] [Related]
22. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
Wu YH; Chen PL; Hung YP; Ko WC
J Microbiol Immunol Infect; 2014 Jun; 47(3):197-203. PubMed ID: 23063776
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with community-acquired urinary tract infections among adults attending assessment centre, Mulago Hospital Uganda.
Kabugo D; Kizito S; Ashok DD; Graham KA; Nabimba R; Namunana S; Kabaka MR; Achan B; Najjuka FC
Afr Health Sci; 2016 Dec; 16(4):1131-1142. PubMed ID: 28479906
[TBL] [Abstract][Full Text] [Related]
25. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network].
Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R
Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802
[TBL] [Abstract][Full Text] [Related]
26. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
[TBL] [Abstract][Full Text] [Related]
27. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
Veve MP; Wagner JL; Kenney RM; Grunwald JL; Davis SL
Int J Antimicrob Agents; 2016 Jul; 48(1):56-60. PubMed ID: 27234673
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.
Kothari A; Sagar V
J Infect Dev Ctries; 2008 Oct; 2(5):354-8. PubMed ID: 19745502
[TBL] [Abstract][Full Text] [Related]
29. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
30. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Dakar, Senegal: a multicenter study.
Dromigny JA; Ndoye B; Macondo EA; Nabeth P; Siby T; Perrier-Gros-Claude JD
Diagn Microbiol Infect Dis; 2003 Dec; 47(4):595-600. PubMed ID: 14711481
[TBL] [Abstract][Full Text] [Related]
31. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
[TBL] [Abstract][Full Text] [Related]
32. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
[TBL] [Abstract][Full Text] [Related]
33. Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners.
Zucconi A; Courjon J; Maruéjouls C; Saintpère F; Degand N; Pandiani L; Pradier C; Mondain V
Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):983-986. PubMed ID: 29594799
[TBL] [Abstract][Full Text] [Related]
34. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
36. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
[TBL] [Abstract][Full Text] [Related]
37. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI
Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654
[TBL] [Abstract][Full Text] [Related]
38. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
Osthoff M; McGuinness SL; Wagen AZ; Eisen DP
Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526
[TBL] [Abstract][Full Text] [Related]
39. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
40. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.
Kahlmeter G
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():15-22; discussion 63-5. PubMed ID: 11051619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
